Sangamo Therapeutics
SGMO
#10605
Rank
A$44.62 M
Marketcap
A$0.11
Share price
0.00%
Change (1 day)
-86.20%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$0.11 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are A$0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.12 B-69.23%
2022-12-31A$0.39 B-17.76%
2021-12-31A$0.47 B-16.68%
2020-12-31A$0.57 B96.17%
2019-12-31A$0.29 B-7.66%
2018-12-31A$0.31 B150.18%
2017-12-31A$0.12 B320.63%
2016-12-31A$30.09 M-11.57%
2015-12-31A$34.03 M-23.85%
2014-12-31A$44.69 M108.43%
2013-12-31A$21.44 M26.35%
2012-12-31A$16.97 M141.56%
2011-12-31A$7.02 M0.63%
2010-12-31A$6.98 M-59.94%
2009-12-31A$17.42 M-1.26%
2008-12-31A$17.65 M31.03%
2007-12-31A$13.47 M50.1%
2006-12-31A$8.97 M-41.2%
2005-12-31A$15.26 M403.08%
2004-12-31A$3.03 M43.56%
2003-12-31A$2.11 M-39.89%
2002-12-31A$3.51 M-32.74%
2001-12-31A$5.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$168.70 B 146,752.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$122.20 B 106,274.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$19.27 B 16,674.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
A$63.06 B 54,792.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$54.76 B 47,565.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$127.83 B 111,174.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$6.39 B 5,463.63%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$7.86 B 6,744.59%๐Ÿ‡บ๐Ÿ‡ธ USA